FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Bacteriostatic 0.9% Sodium Chloride Injection
Status: Currently in Shortage
»Date first posted: 12/08/2021
»Therapeutic Categories: Gastroenterology; Other; Pediatric

Expand all

Fresenius Kabi USA, LLC (Reverified 01/18/2022)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
0.9% (90 mg per 10 mL), (9mg/mL), Multiple Dose Plastic Vial, 30 mL (NDC 63323-924-30) Backordered. Next release March 2022. Increase in demand
0.9% (90 mg per 10 mL), (9mg/mL), Multiple Dose Plastic Vial, 10 mL, (NDC 63323-924-10) Backordered. Next release March 2022. Increase in demand

Hospira, Inc. (Revised 01/05/2022)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
10 mL Multiple Dose LifeShield™ Plastic Fliptop Vial (NDC 00409-1966-12) Next Delivery: February 2022; Estimated Recovery: November 2022 Demand increase for the drug
20 mL Multiple Dose Plastic Fliptop Vial (NDC 00409-1966-05) Next Delivery: March 2022; Estimated Recovery: May 2022 Demand increase for the drug
30 mL Multiple Dose Plastic Fliptop Vial (NDC 00409-1966-07) Next Delivery: January 2022; Estimated Recovery: December 2022 Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English